Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

• Status: Enrolling by invitation
• Trial end date: 2022-11-30
• Target enrollment: 0
• Participant gender: Female

Summary

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Treatments: Methyltestosterone; Prolactin Release-Inhibiting Factors; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Clinical Diagnosis of Polycystic Ovary Syndrome

• Able to inject study drug

• Able to swallow pills

Controls:

-Diagnosis of Insulin resistance

Exclusion Criteria:

• Any woman that does not fit the inclusion criteria

• Males